The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The economic cost of brain disorders in Europe
Abstract
Background and purpose: In 2005, we presented for the first time overall estimates of annual costs for brain disorders (mental and neurologic disorders) in Europe. This new report presents updated, more accurate, and comprehensive 2010 estimates for 30 European countries. Methods: One‐year prevalence and annual cost per person of 19 major groups of disorders are based on ‘best estimates’ derived from systematic literature reviews by panels of experts in epidemiology and health economics. Our cost estimation model was populated with national statistics from Eurostat to adjust to 2010 values, converting all local currencies to Euros (€), imputing cost for countries where no data were available, and aggregating country estimates to purchasing power parity–adjusted estimates of the total cost of brain disorders in Europe in 2010. Results: Total European 2010 cost of brain disorders was €798 billion, of which direct health care cost 37%, direct non‐medical cost 23%, and indirect cost 40%. Average cost per inhabitant was €5.550. The European average cost per person with a disorder of the brain ranged between €285 for headache and €30 000 for neuromuscular disorders. Total annual cost per disorder (in billion € 2010) was as follows: addiction 65.7; anxiety disorders 74.4; brain tumor 5.2; child/adolescent disorders 21.3; dementia 105.2; eating disorders 0.8; epilepsy 13.8; headache 43.5; mental retardation 43.3; mood disorders 113.4; multiple sclerosis 14.6; neuromuscular disorders 7.7; Parkinson’s disease 13.9; personality disorders 27.3; psychotic disorders 93.9; sleep disorders 35.4; somatoform disorder 21.2; stroke 64.1; and traumatic brain injury 33.0. Conclusion: Our cost model revealed that brain disorders overall are much more costly than previously estimated constituting a major health economic challenge for Europe. Our estimate should be regarded as conservative because many disorders or cost items could not be included because of lack of data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Self-citationCost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
Self-citationCost of disorders of the brain in Europe
Andlin‐Sobocki, P., Jönsson, B., Wittchen, H., & Olesen, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01202.x · Cited by 1,139
Self-citationDiagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Diagnostic and Statistical Manual
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5484 · Cited by 734
The epidemiology of anxiety disorders: prevalence and societal costs.
Lépine, J. (2002) · PubMed · Cited by 396
Revealing the cost of Type II diabetes in Europe
Jönsson, B. (2002) · Diabetologia · doi:10.1007/s00125-002-0858-x · Cited by 392
Self-citationThe Economic Impact of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Pelham, W. E., Foster, E. M., & Robb, J. A. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm022 · Cited by 327
International Comparison of Stroke Cost Studies
Evers, S. M. A. A., Struijs, J. N., Ament, A. J. H. A., van Genugten, M. L. L., Jager, J. (. C., & van den Bos, G. A. M. (2004) · Stroke · doi:10.1161/01.str.0000125860.48180.48 · Cited by 265
The burden of brain diseases in Europe
Olesen, J., & Leonardi, M. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00682.x · Cited by 242
Self-citationKleinman, L. S., Lowin, A., Flood, E., Gandhi, G., Edgell, E., & Revicki, D. A. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321090-00001 · Cited by 237
The economic impact of dementia in Europe in 2008—cost estimates from the Eurocode project
Wimo, A., Jönsson, L., Gustavsson, A., McDaid, D., Ersek, K., Georges, J., Gulácsi, L., Karpati, K., Kenigsberg, P., & Valtonen, H. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2610 · Cited by 210
Self-citationThe prevalence, cost implications, and management of sleep disorders: an overview
Hossain, J. L., & Shapiro, C. M. (2002) · Sleep And Breathing · doi:10.1055/s-2002-32322 · Cited by 195
The Prevalence, Cost Implications, and Management of Sleep Disorders: An Overview
Hossain, J. L., & Shapiro, C. M. (2002) · Sleep and Breathing · doi:10.1007/s11325-002-0085-1 · Cited by 194
Economic Burden of Prescription Opioid Misuse and Abuse
Strassels, S. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.7.556 · Cited by 146
The cost of migraine and its treatment.
Goldberg, L. D. (2005) · PubMed · Cited by 140
Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society
Halpin, D. M. G., & Miravitlles, M. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-093ss · Cited by 139
Nutt, D., & Goodwin, G. M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.05.004 · Cited by 99
Estimating the Costs of Epilepsy: An International Comparison of Epilepsy Cost Studies
Kotsopoulos, I. A. W., Evers, S., Ament, A. J. H. A., & de Krom, M. C. T. F. M. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.18200.x · Cited by 71
Consensus Document on European Brain Research
Luca, M. D., Baker, M. G., Corradetti, R., Kettenmann, H., Mendlewicz, J., Olesen, J., Ragan, I., & Westphal, M. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07596.x · Cited by 63
Self-citationKobelt, G., Texier-Richard, B., & Lindgren, P. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102771 · Cited by 48
BMJ Publishing Group Ltd (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.089540 · Cited by 48
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30371-x · Cited by 2,609
Short- and long-term health consequences of sleep disruption
Medic, G., Wille, M., & Hemels, M. (2017) · Nature and Science of Sleep · doi:10.2147/nss.s134864 · Cited by 1,776
A review of depression and suicide risk assessment using speech analysis
Cummins, N., Scherer, S., Krajewski, J., Schnieder, S., Epps, J., & Quatieri, T. F. (2015) · Speech Communication · doi:10.1016/j.specom.2015.03.004 · Cited by 1,003
The resilience framework as a strategy to combat stress-related disorders
Kalisch, R., Baker, D. G., Basten, U., Boks, M. P., Bonanno, G. A., Brummelman, E., Chmitorz, A., Fernàndez, G., Fiebach, C. J., Galatzer-Levy, I., et al. (2017) · Nature Human Behaviour · doi:10.1038/s41562-017-0200-8 · Cited by 782
Metadata
- Authors
- Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H. ‐., Jönsson, B., on behalf of the CDBE2010 study group, & the European Brain Council
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2011-12-19
- Volume
- 19
- Issue
- 1
- Pages
- 155-162
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2146890278
- Cited by
- 1,481
- References
- 22
- FWCI
- 164.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.